RI-AME Study OF [ISOTHIAZOLYL-3-14C]-LURASIDONE

Clinical trial NCT01082146 · COMPLETED

Trial details

NCT number: NCT01082146
Sponsor: Sumitomo Pharma America, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pharmacokinetics Metabolism

Start date: 2008-08-01
Primary completion: 2008-08-01
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.